Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05354778Not ApplicableRecruiting

HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study

Role: collaborator

NCT04267315Phase 2Unknown

Trigger Point Injections for Post-Mastectomy Pain Syndrome

Role: collaborator

NCT04018235Completed

Psychometric Properties of the Updated Module on Assessing Quality of Life of Patients With Breast Cancer

Role: collaborator

NCT03209076Not ApplicableUnknown

Robotic Versus Laparoscopic Low Anterior Resection for Rectal Cancer

Role: collaborator

NCT02107417Not ApplicableUnknown

Study of TENS in Reducing Symptoms of Peripheral Neuropathy Induced by Chemotherapy

Role: collaborator

All 5 trials loaded